Management of Depression and Insomnia in Elderly Patients

Pharmacological Treatment

The American Geriatrics Society recommends against benzodiazepines in elderly patients due to risks of dependency, falls, cognitive impairment, and respiratory depression that substantially outweigh any benefits 2, 3
If insomnia persists or worsens on sertraline, the American Academy of Sleep Medicine suggests adding low-dose doxepin (3-6 mg) at bedtime rather than switching antidepressants 2, 3
Low-dose doxepin is the most appropriate medication for sleep maintenance insomnia in older adults, with high-strength evidence for efficacy and does not carry black box warnings 2, 3
Mirtazapine is associated with weight gain, which may be problematic in some elderly patients 4

Review all current medications for sleep-disrupting agents, including β-blockers, bronchodilators, corticosteroids, decongestants, diuretics, and other SSRIs/SNRIs, as they all contribute to insomnia 1, 3
Assess for medical comorbidities, such as cardiac disease, pulmonary disease, pain from osteoarthritis, nocturia, and neurologic deficits, which commonly contribute to insomnia in elderly patients 1, 3
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be initiated concurrently with pharmacotherapy, as it provides superior long-term outcomes with sustained benefits up to 2 years 2, 3
Sleep hygiene education, including maintaining stable bedtimes, avoiding daytime napping, and limiting caffeine, should be implemented 1, 3

Monitor closely for adverse effects, including next-day impairment, falls, confusion, hyponatremia, and behavioral abnormalities 3
Reassess insomnia symptoms after 2-4 weeks; if sleep disturbance persists despite improved mood, add low-dose doxepin (3-6 mg) rather than increasing sertraline dose 2, 5